CALR and neoplasm: Different from directly delivering immunotherapeutic agents to tumor tissue, PDT could evoke anti‐tumor immunity by inducing immunogenic cell death (ICD) that involved the up‐regulated expression of calreticulin (CRT) on the cell surface.[70] The CRT exposure on the membrane of tumor cells can promote the activation and maturation of DCs.